Roivant Sciences President and Immunovant CEO Eric Venker sells $7.26 million in Roivant common shares
ROIV•Eric Venker sold 200,000 Roivant Sciences common shares on Nov. 3, 2026, at $36.31 per share, leaving him with 999,154 directly held shares.
1. Share sale
A Nov. 5 filing reported that Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on Nov. 3, 2026, at $36.31 per share. He retained 999,154 directly held common shares.
